10 — Altered intercellular communication
"Integrative" hallmark (López-Otín et al., Cell 2023, 10.1016/j.cell.2022.11.001). It describes how the messages exchanged between cells, tissues and organs go wrong with age, spreading aging from one part of the body to another.
1. Definition
Cells talk to each other constantly: hormones, growth factors, inflammatory molecules, vesicles, contacts with the matrix that surrounds them. With age, this dialogue becomes scrambled. The blood of an old organism carries more harmful signals and fewer protective ones, and the "scaffolding" of tissues (extracellular matrix) stiffens.
In plain terms: imagine a company where internal messages are distorted and rumours (inflammation) spread faster than good instructions. Even if each employee stays competent, the whole works badly.
2. Mechanisms and sources
2.1 The blood environment (systemic factors)
The founding experiment is heterochronic parabiosis: the circulations of a young mouse and an old mouse are surgically joined.
- Young blood restores the activity of muscle and liver stem cells in the old animal (Conboy 2005, 10.1038/nature03260).
- Conversely, old blood reduces neurogenesis and cognitive abilities in the young mouse; the chemokine CCL11 (eotaxin) is one of the culprits (Villeda 2011, 10.1038/nature10357).
- Injecting young plasma alone improves synaptic plasticity and memory in old mice (Villeda 2014, 10.1038/nm.3569); young factors also rejuvenate brain blood vessels (Katsimpardi 2014, 10.1126/science.1251141).
- A single blood exchange is enough to show that the inhibitory effect of old blood is fast and strong, often more so than the beneficial effect of young blood (Rebo 2016, 10.1038/ncomms13363). Diluting old plasma with a saline-albumin solution rejuvenates several tissues in mice (Mehdipour 2020, 10.18632/aging.103418).
In plain terms: removing the "bad messages" from old blood seems to matter at least as much as adding young "good messages".
- Candidate factors: GDF11 was presented as a rejuvenating young factor, but a contradictory study found that it increases with age and inhibits muscle regeneration (Egerman 2015, 10.1016/j.cmet.2015.05.010): the subject remains controversial. Other leads: umbilical cord plasma proteins (TIMP2) (Castellano 2017, 10.1038/nature22067), and the liver enzyme GPLD1, which transfers the benefits of exercise to the brain (Horowitz 2020, 10.1126/science.aaw2622).
- Klotho: an anti-aging hormone whose loss in mice causes a syndrome resembling aging (Kuro-o 1997, 10.1038/36285).
2.2 The control centres (neuroendocrine axes)
The hypothalamus, the brain region that steers hormones and metabolism, acts as a conductor of aging. Local inflammation there (IKK-β/NF-κB pathway) accelerates systemic aging in mice, and blocking it extends life (Zhang 2013, 10.1038/nature12143). Hypothalamic stem cells slow aging partly through microRNAs carried in exosomes (small vesicles) (Zhang 2017, 10.1038/nature23282).
2.3 The secretion of senescent cells (SASP)
Senescent cells (see 08) secrete an inflammatory cocktail (SASP) that makes their neighbours senescent: this is paracrine senescence, orchestrated by the inflammasome (Acosta 2013, 10.1038/ncb2784). Transplanting a few senescent cells into a young mouse is enough to cause lasting physical dysfunction (Xu 2018, 10.1038/s41591-018-0092-9).
2.4 The extracellular matrix
The matrix is the network of proteins (collagen, elastin) that surrounds cells and transmits mechanical signals to them. With age, it stiffens (cross-links, glycation) and becomes disorganised. In the worm C. elegans, collagen remodelling is required for the longevity induced by the insulin/IGF-1 pathway (Ewald 2014, 10.1038/nature14021). In humans, causal data are lacking: the link is mostly correlational (fibrosis, arterial stiffness).
3. Symptoms and clinical manifestations
- Fibrosis (lung, kidney, heart, liver): accumulation of stiff matrix, often promoted by the SASP.
- Arterial stiffness and hypertension in older people.
- Cognitive decline correlated with blood factors (CCL11 and others, mostly shown in mice).
- Hormonal disturbances: menopause, andropause, decline in growth hormone and IGF-1, insulin resistance.
- Immunosenescence: weaker response to vaccines, more infections; closely linked to chronic inflammation (11).
- Human evidence: the plasma proteome changes markedly with age, but the causal effects of blood factors have been shown only in animals. Plasma trials in humans are rare and small (see table).
4. Interactions with the other hallmarks
- Genomic instability (01) and telomere attrition (02): damage triggers senescence, hence the SASP.
- Epigenetic alterations (03): blood factors modify the epigenetic state of target cells.
- Loss of proteostasis (04): extracellular vesicles carry misfolded proteins between cells.
- Disabled macroautophagy (05): takes part in controlling cell secretion.
- Deregulated nutrient sensing (06): insulin, IGF-1 and growth hormone are central messengers; the same pathway is linked to collagen in the worm (Ewald 2014).
- Mitochondrial dysfunction (07): mitochondrial stress signals (mitokines) circulate in the blood.
- Cellular senescence (08): the SASP is the main channel of propagation (Acosta 2013).
- Stem cell exhaustion (09): old blood inhibits stem cells (Conboy 2005).
- Chronic inflammation (11): the most visible form of altered communication.
- Dysbiosis (12): the microbiota communicates with the host through its metabolites (gut-brain and gut-immunity axes).
5. Existing or investigational remedies
| Intervention | Target | Level of evidence | Key result | Source |
|---|---|---|---|---|
| Heterochronic parabiosis | Blood environment | Preclinical (mice) | Rejuvenation of muscle, liver, brain | Conboy 2005 ; Villeda 2011 |
| Young plasma injection | Blood factors | Preclinical (mice) | Improved memory and synaptic plasticity | Villeda 2014 |
| Dilution of old plasma (saline-albumin) | Harmful blood factors | Preclinical (mice) | Several tissues rejuvenated | Mehdipour 2020 |
| Plasma exchange with albumin (AMBAR) | Moderate Alzheimer's disease | Human phase IIb/III trial | Slower decline on some endpoints, mixed results | Boada 2020 |
| Young plasma infusion (PLASMA) | Alzheimer's disease | Human phase I trial | Safe and feasible, no efficacy shown (small sample) | Sha 2019 |
| Cord plasma proteins (TIMP2) | Hippocampus | Preclinical (mice) | Improved hippocampal function | Castellano 2017 |
| GPLD1 (exercise factor) | Neurogenesis | Preclinical (mice) | Improved cognition in old animals | Horowitz 2020 |
| Inhibition of hypothalamic NF-κB | Hypothalamus | Preclinical (mice) | Slower aging, longer life | Zhang 2013 |
| Senolytics (dasatinib + quercetin) | Senescent cells / SASP | Preclinical (mice); first human trials (see 08, 11) | Improved physical function and survival | Xu 2018 |
| Physical exercise | Circulating factors, hormones | Recommended (not a formal "anti-aging" indication) | Transfers benefits through the blood in mice | Horowitz 2020 |
No intervention on intercellular communication is approved against aging. Commercial clinics have sold young plasma infusions with no proof of efficacy; the FDA issued a warning on 19 February 2019: no proven clinical benefit, real risks (FDA 2019).
6. Open questions
- Which factors really matter? Hundreds of proteins change in the blood; few are validated, and some (GDF11) are controversial.
- Remove or add? The data of Rebo 2016 and Mehdipour 2020 suggest that removing the "bad" is more effective than adding the "good": to be confirmed in humans.
- Duration of the effect: does a plasma exchange have a lasting effect, or must it be repeated indefinitely?
- Extracellular matrix: can stiffening be reversed (cross-link breakers)? Few effective tools so far.
- Translation: human trials (AMBAR, PLASMA) target diseases, not aging itself; validated endpoints for aging are lacking.
7. References
- López-Otín C. et al. (2023) Hallmarks of aging: An expanding universe. Cell. 10.1016/j.cell.2022.11.001
- Conboy I.M. et al. (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 10.1038/nature03260
- Villeda S.A. et al. (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 10.1038/nature10357
- Villeda S.A. et al. (2014) Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nature Medicine. 10.1038/nm.3569
- Katsimpardi L. et al. (2014) Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science. 10.1126/science.1251141
- Egerman M.A. et al. (2015) GDF11 increases with age and inhibits skeletal muscle regeneration. Cell Metabolism. 10.1016/j.cmet.2015.05.010
- Rebo J. et al. (2016) A single heterochronic blood exchange reveals rapid inhibition of multiple tissues by old blood. Nature Communications. 10.1038/ncomms13363
- Castellano J.M. et al. (2017) Human umbilical cord plasma proteins revitalize hippocampal function in aged mice. Nature. 10.1038/nature22067
- Mehdipour M. et al. (2020) Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin. Aging. 10.18632/aging.103418
- Horowitz A.M. et al. (2020) Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain. Science. 10.1126/science.aaw2622
- Boada M. et al. (2020) A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: primary results of the AMBAR study. Alzheimer's & Dementia. 10.1002/alz.12137
- Sha S.J. et al. (2019) Safety, tolerability, and feasibility of young plasma infusion in the Plasma for Alzheimer Symptom Amelioration study. JAMA Neurology. 10.1001/jamaneurol.2018.3288
- Kuro-o M. et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 10.1038/36285
- Zhang G. et al. (2013) Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH. Nature. 10.1038/nature12143
- Zhang Y. et al. (2017) Hypothalamic stem cells control ageing speed partly through exosomal miRNAs. Nature. 10.1038/nature23282
- Acosta J.C. et al. (2013) A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nature Cell Biology. 10.1038/ncb2784
- Xu M. et al. (2018) Senolytics improve physical function and increase lifespan in old age. Nature Medicine. 10.1038/s41591-018-0092-9
- U.S. Food and Drug Administration (2019) Important information about young donor plasma infusions for profit. Safety communication, 19 February 2019. fda.gov
- Ewald C.Y. et al. (2014) Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity. Nature. 10.1038/nature14021